Data integration has been a pharma industry buzzword for the last few years. Despite pharma companies having access to several internal and external data sources, staff are still working in silos and are not aware of all the data available to them.
A typical trial feasibility analysis can take six weeks or more, and nearly one-third of qualified investigators may be overlooked. Innovations in data mapping and semantic linking are producing business intelligence tools that aggregate information on sponsors, sites, investigators, trials, publications and presentations, effectively breaking down these silos and helping clinical development teams operate more efficiently.
During this free webinar, the featured speaker will discuss how the evolution in clinical business intelligence is addressing the typical challenges of trial feasibility analyses through:
- Intelligent, robotic classification of sites, drugs, investigators, sponsors, etc.
- Objective scoring and ranking of investigators ranked academic and trial experience
- Data mining of clinically relevant scientific publications and presentations
- Insightful analytics with low user threshold
- Data-driven evidence to improve trial planning and site selection
- Up-to-date, publicly available data to inform competitive intelligence and disease landscaping
John Coritz, US Data Division Manager, Anju Software
John Coritz currently serves as the US data division manager for Anju Software. Prior to joining Anju, he held multiple roles in clinical trial operations at GSK, eventually transitioning into digital technology and strategic clinical planning. He is an advocate for bringing all actionable business intelligence sources together to make educated business decisions.Message Presenter
Who Should Attend?
This webinar will appeal to senior-level managers, leaders and executives working in the following or related departments:
- Clinical Operations
- Trial Planning
- Site Selection
- Medical Affairs
What You Will Learn
Attendees will learn about:
- Challenges introduced by disparate data sources and the impact on trial planning and other clinical operations
- How business intelligence tools are addressing the differing data requirements of multiple pharma teams (e.g. Clinical Operations, IT, Regulatory, Project Management, etc.)
- The value of a business intelligence tool in driving evidence-based decisions for trial feasibility and disease landscaping
OmniComm Systems, an Anju Software Company, is a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services to pharmaceutical and biotech companies, contract research organizations and other clinical trial sponsors principally located in the United States, Europe and East Asia. OmniComm’s proprietary EDC and eClinical software applications – TrialMaster®, TrialOne®, eClinical Suite, Promasys®, IRTMaster, AutoEncoder and Acuity – allow clinical trial sponsors and investigative sites to securely collect, validate, transmit and analyze clinical trial data. OmniComm is headquartered in Fort Lauderdale, FL. Anju Software, Inc. is a leading provider of comprehensive software solutions to the life sciences industry that provides an integrated platform spanning clinical operations, medical affairs and commercial divisions, including integrated data intelligence. Anju is a privately owned, Abry Partners portfolio company.